Drug General Information (ID: DDIL27KNXU)
  Drug Name Nitroprusside Drug Info Guanabenz Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antihypertensive Agents Sympatholytics
  Structure

 Mechanism of Nitroprusside-Guanabenz Interaction (Severity Level: Moderate)
     Additive hypotensive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Nitroprusside Guanabenz
      Mechanism Antihypertensive agent
Guanylate cyclase  Agonist
Antihypertensive agent
Alpha-2 adrenergic receptor  Agonist
      Key Mechanism Factor 1
Factor Name Guanylate cyclase soluble Structure Sequence
Protein Family Adenylyl cyclase class-4/guanylyl cyclase family
Protein Function
There are two types of guanylate cyclases: soluble forms and membrane-associated receptor forms. Activated by nitric oxide in the presence of magnesium or manganese ions.
    Click to Show/Hide
      Key Mechanism Factor 2
Factor Name Adrenergic receptor alpha-2 Structure Sequence
Protein Family G-protein coupled receptor 1 family
Protein Function
Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol.
    Click to Show/Hide
      Mechanism Description
  • Additive hypotensive effects by the combination of Nitroprusside and Guanabenz 

Recommended Action
      Management Management consists of carefully monitoring hemodynamics during coadministration and titrating the dosage of nitroprusside as necessary.

References
1 Product Information. Tenex (guanfacine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
2 Product Information. Nipride (nitroprusside). Roche Laboratories, Nutley, NJ.
3 Cohen IM, Mottet MM, Francis GS, Alpert JS "Danger in nitroprusside therapy." Ann Intern Med 85 (1976): 205-6